Leadership Overview
Merck KGaA has 10 executives leading key functions including finance, operations, marketing, and strategy.
Driven by a legacy of innovation, Merck KGaA is dedicated to advancing science and technology to improve lives globally, operating across diverse sectors with a commitment to research and development.
Driven by a legacy of innovation, Merck KGaA is dedicated to advancing science and technology to improve lives globally, operating across diverse sectors with a commitment to research and development.
Leadership Roles at Merck KGaA
Adriaan Strydom - Chief Financial Officer
Adriaan Strydom, the Chief Financial Officer at Merck KGaA, directs the company's global financial strategy and operations. This leadership role involves overseeing all fiscal activities, including financial planning, risk management, and capital allocation across Europe, Africa, Asia, Oceania, and the Americas. Strydom ensures robust financial controls and compliance with international regulations, supporting Merck KGaA's significant investments in research and development centers located in Darmstadt, Boston, Tokyo, and Beijing. The Chief Financial Officer's oversight extends to optimizing financial performance and driving sustainable growth by aligning fiscal policies with the company's long-term objectives in the pharmaceutical, chemical, and life sciences sectors. Adriaan Strydom's strategic financial guidance is critical for maintaining the company's competitive edge and facilitating its multinational expansion.
Gladys Lorenzana - Chief Financial Officer Clúster Norte
Gladys Lorenzana, the Chief Financial Officer Clúster Norte at Merck KGaA, manages financial operations and strategic planning for the Northern Cluster region. This executive oversees all financial activities, including budgeting, forecasting, and financial reporting, ensuring fiscal discipline and compliance within the designated geographical area. Lorenzana's role is critical in supporting regional business objectives and optimizing financial performance for Merck KGaA's pharmaceutical, chemical, and life sciences operations in this cluster. The Chief Financial Officer Clúster Norte collaborates closely with local leadership to drive profitability and manage financial risks effectively. Gladys Lorenzana's financial acumen contributes to the robust financial health and strategic growth of Merck KGaA within its key markets.
Rossy Flores - Chief Financial Officer (México)
Rossy Flores, the Chief Financial Officer (México) at Merck KGaA, leads financial strategy and management for the Mexican operations. This executive is responsible for overseeing all financial aspects, including budgeting, financial planning, analysis, and reporting within the region. Flores ensures adherence to local financial regulations and corporate policies, supporting the strategic objectives of Merck KGaA's pharmaceutical, chemical, and life sciences businesses in Mexico. The Chief Financial Officer (México) plays a crucial role in driving financial performance, managing fiscal risks, and contributing to the sustainable growth of the company in this key market. Rossy Flores's financial expertise is essential for maintaining fiscal health and supporting operational expansion.
Edward Shober - Chief Operating Officer
Edward Shober, the Chief Operating Officer at Merck KGaA, orchestrates the company's global operational execution and efficiency. This executive directs the day-to-day business activities, ensuring seamless integration of operations across its diverse business units in the pharmaceutical, chemical, and life sciences industries. Shober's responsibilities encompass optimizing supply chains, managing production facilities, and driving operational excellence across all regions, including Europe, Africa, Asia, Oceania, and the Americas. The Chief Operating Officer plays a pivotal role in scaling operations to support major research and development initiatives in key global centers. Edward Shober's focus is on enhancing productivity, implementing best practices, and ensuring that operational frameworks directly support Merck KGaA's mission of advancing science for human progress.
Stephanie Chapman - Chief of Staff
Stephanie Chapman, the Chief of Staff at Merck KGaA, provides strategic support and operational coordination for executive leadership. This role involves managing key initiatives, facilitating cross-functional collaboration, and ensuring alignment across departments in the pharmaceutical, chemical, and life sciences sectors. Chapman's responsibilities include streamlining communication channels, preparing executive briefings, and driving the execution of strategic projects across global operations in Europe, Africa, Asia, Oceania, and the Americas. The Chief of Staff acts as a key liaison, ensuring that executive priorities are translated into actionable plans. Stephanie Chapman's strategic insights and organizational acumen are vital for enhancing the effectiveness of the leadership team and supporting Merck KGaA's commitment to innovation and scientific advancement.
Margaret Sedam - Chief Marketing Officer
Margaret Sedam, the Chief Marketing Officer at Merck KGaA, spearheads the company's global marketing strategies and brand development across its pharmaceutical, chemical, and life sciences divisions. This executive directs market research, product positioning, and promotional campaigns to enhance brand visibility and market penetration in Europe, Africa, Asia, Oceania, and the Americas. Sedam's leadership focuses on understanding customer needs and translating market insights into effective go-to-market strategies that support the company's innovation pipeline. The Chief Marketing Officer plays a crucial role in communicating the value of Merck KGaA's scientific advancements and product offerings to diverse global audiences. Margaret Sedam's expertise drives brand equity and supports the company's mission to improve health and well-being through science.
Julie Perrone - Director, Communication & Chief of Staff
Julie Perrone, the Director, Communication & Chief of Staff at Merck KGaA, directs integrated communication strategies and provides executive operational support. This dual role involves shaping the company's public image and facilitating the efficient execution of leadership directives across its global pharmaceutical, chemical, and life sciences businesses. Perrone manages internal and external communications, ensuring consistent messaging and brand alignment throughout Europe, Africa, Asia, Oceania, and the Americas. As Chief of Staff, Julie Perrone enhances leadership effectiveness by coordinating strategic initiatives and streamlining operational processes. This leadership position is instrumental in fostering strong stakeholder relationships and advancing Merck KGaA's mission through clear, impactful communication and strategic operational management.
Komal Desai - Digital & Data Quality Chief of Staff
Komal Desai, the Digital & Data Quality Chief of Staff at Merck KGaA, drives initiatives focused on enhancing digital transformation and ensuring data integrity across the organization. This executive oversees the strategic implementation of digital solutions and robust data quality frameworks within the pharmaceutical, chemical, and life sciences sectors. Desai's responsibilities include improving data governance, optimizing digital workflows, and ensuring that data-driven insights support critical business decisions across global operations. The Digital & Data Quality Chief of Staff collaborates with technology and business units to advance Merck KGaA's digital capabilities. Komal Desai's focus on data excellence and digital innovation is key to maintaining the company's competitive advantage and scientific leadership.
Anthony Martorano - Lead Director, Strategic Operations & Chief of Staff
Anthony Martorano, the Lead Director, Strategic Operations & Chief of Staff at Merck KGaA, directs critical strategic operations and provides high-level support to executive leadership. This role involves developing and implementing strategic initiatives that enhance operational efficiency and drive business growth across the company's pharmaceutical, chemical, and life sciences divisions. Martorano oversees key operational projects, ensuring alignment with corporate objectives and facilitating seamless execution across global markets. As Chief of Staff, Anthony Martorano supports the executive team by managing complex projects and optimizing organizational processes. This leadership position is vital for advancing Merck KGaA's strategic agenda and ensuring operational excellence in its worldwide endeavors.
Jc Requeima - Chief Marketing Officer, Latin America
Jc Requeima, the Chief Marketing Officer, Latin America at Merck KGaA, directs comprehensive marketing strategies and brand initiatives across the Latin American region. This executive oversees market analysis, product launches, and promotional activities for the company's pharmaceutical, chemical, and life sciences portfolios. Requeima's leadership focuses on understanding regional market dynamics and consumer needs to drive brand awareness and market share growth. The Chief Marketing Officer, Latin America collaborates with local teams to ensure effective execution of marketing plans and alignment with global brand standards. Jc Requeima's strategic marketing vision is critical for enhancing Merck KGaA's presence and impact throughout Latin America.
Explore Leadership Teams in Manufacturing
Catalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad, deep-scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred Contract Development and Manufacturing Organization (CDMO) partner for personalized medicines, blockbuster drugs and consumer health brand extensions.
Company Leadership


Jubilant Pharmova is a patient-focused biopharmaceutical company based in Noida, India.
Company Leadership AC

SJ
VK
Cohance is a global Contract Development and Manufacturing Organization (CDMO) specializing in Antibody Drug Conjugates (ADCs), Nucleic Acid Chemistry, and Small Molecules. The company offers a wide range of services including API development, manufacturing, and clinical analytical services, aimed at accelerating the pipeline for pharmaceutical innovators. With a commitment to sustainability and quality, Cohance partners with clients to provide integrated solutions from discovery to commercial scale. Their expertise and innovative approach make them a trusted partner for complex molecule development and manufacturing needs.
Company Leadership
YD
HA
GB
Samsung Biologics Co.,Ltd. engages in the contract development and manufacturing organization (CDMO) business for biopharmaceuticals products in South Korea, Europe, the United States, and internationally. The company operates in two segments, CDMO, and Biopharmaceutical Development and Commercialization. Its development services include discovery, cell line development, process development, and clinical manufacturing. The company also offers aseptic filling, lyophilization, finishing, storage and shipping, and support services; and quality assurance and control, as well as biosafety and analytical testing services. In addition, it engages in the research and commercialization of biosimilar drugs; development and manufacture of antibody-drug conjugates; and manufactures mammalian and mRNA products. The company was founded in 2011 and is headquartered in Incheon, South Korea.
Company Leadership
BB
YK
TK